A Study to Determine Biopsy Rate in Participants With a First Relapse of Breast Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

76 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-06-30

Study Completion Date

2016-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a retrospective, and observational cohort study to determine the proportion of breast cancer first relapses, that are biopsied. The duration of the study will be approximately 24 months.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Prospective Longitudinal Breast Cancer Study

NCT02270931

Breast Cancer

COMPLETED

Breast Cancer 2-PREVENT Translational Center of Excellence (TCE) - Metastatic Markers of Recurrent Tumor Phenotype for Breast Cancer

NCT02530008

Women With Suspected or Confirmed Recurrent Breast Cancer

ACTIVE_NOT_RECRUITING

Partial Breast Re-irradiation in Women in Women with Locally Recurrent Breast Cancer Previously Treated with Conservative Surgery and Whole Breast Irradiation

NCT05772390

Breast Cancer Recurrent

RECRUITING PHASE2

Prospective Observational Study for Breast Microcalcifications' Classification With Artificial Intelligence Techniques

NCT05767424

Breast Cancer Microcalcification

ACTIVE_NOT_RECRUITING

Predictive Clinical and Biological Parameters in Breast Cancer

NCT01521676

Breast Cancer

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

eBC treated participants

Participants with metastatic disease after previously being treated for eBC were observed for 24 months.

eBC treated participants

Intervention Type OTHER

No intervention administered in this retrospective observational study.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

eBC treated participants

No intervention administered in this retrospective observational study.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants with histologically confirmed breast cancer treated for early breast cancer (eBC) with first metastatic relapse disease in the period from January 1, 2014 and December 31, 2015